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Purpose: To examine the original flowability, compressibility and compactibility of Saraca indica bark 
powder and its tablet formulations.  
Methods: Saraca indica bark powder was subjected to various quantitative tests including acid insoluble 
ash, total ash, foreign organic matter, alcohol soluble extractive and water soluble extractive. Its 
flowability and compressibility were determined using Kawakita, Heckel and Leuenberger relationships. 
Tablets were prepared from the powder by direct compression and wet granulation techniques and 
characterized.  
Results: Kawakita analysis revealed lower cohesiveness of granules (3.877 ± 0.890) compared to the 
powder (6.176 ± 1.030), and hence improved flowability. From Heckel analysis, the higher value of 
intercept (A) for granules (4.38 ± 0.45) implies higher degree of fragmentation than direct compression 
DC formulation (2.90 ± 0.33) and powders (2.44 ± 0.12). The compression susceptibility parameter 
obtained from Leuenberger equation for compacts formed by wet granulation technique (0.183 ± 0.045 
1/kg/cm2) indicate that maximum crushing strength is reached faster at lower pressures of compression 
than for Saraca indica bark powder (0.073 ± 0.025 1/kg/cm2) and DC formulation (0.105 ± 0.033 
1/kg/cm2). In-vitro dissolution study showed that more than a 90%  of tannin was released within 30 and 
60 min from tablets prepared by wet granulation and DC, respectively. Brittle fracture index data indicate 
that tablets prepared from granules showed less fracture, capping and lamination tendencies. 
Conclusion: It is concluded that the desired flowability, compressibility and compactibility of Saraca 
indica bark powder can be obtained by direct compression and wet granulation techniques.  
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INTRODUCTION 
 
The dried stem bark powder of Saraca indica 
(family: Caesalpiniaceae) is a claimed 
wonder herb that cures several diseases. It is 
extensively used in India’s Ayurvedic system 
of medicine for the treatment of a variety of 
ailments such as excessive uterine bleeding 
and stomachache, and as a blood purifier, 
hypothermic and diuretic. Saraca indica is an 
excellent herb for the therapy of 
gynecological problems including uterine 
bleeding associated with fibroids, leucorrhoea 
and menstrual disturbances without 
producing any side effects. It is also used for 
stimulating uterus, endometrium and ovarian 
tissues. Other ailments it is used to treat are 
internal piles, diabetes, dyspepsia, 
indigestion, burning sensation, blood 
disorders, fractures, tumors, bites, 
ulcerations, and skin discoloration [1,2]. 
In spite of their efficacy, herbal medicinal 
products have been widely criticized due to 
lack of standardization and poor-quality 
presentation. Formulation of Saraca indica 
into a modern pharmaceutical conventional 
tablet dosage form would confer on it many of 
the properties of a good tablet, including ease 
of administration, greater patient acceptance, 
prolonged shelf life, quality assurance, 
greater accuracy in dispensing and reduction 
in transportation cost arising perhaps from 
powder formulation into less bulky tablet 
dosage form [3].  
 
The measurement of porosity changes as a 
function of compression pressure is widely 
used in describing powder compressional 
behavior. The compressibility of a powder 
bed could be inferred from the relationship 
between porosity and applied pressure [4]. 
Due to poor flowability and compressibility, 
Saraca indica bark powders necessarily 
require alteration prior to tableting. These 
parameters become more critical when the 
formulation contains a large amount of active 
substance with poor compressional 
properties. However, there are no reports in 
the literature on the optimization of 
micromeritic properties of Saraca indica for 
processing into tablet dosage form. 
Therefore, the aim of present study was to 
develop suitable conventional tablets of 
Saraca indica bark powder for oral 
administration using wet granulation and 
direct compression methods, as well as to 







Standard tannin was obtained gratis from 
Sami Labs, India. Avicel PH 101 and 102 
(FMC Corporation, Philadelphia, USA), cross-
caramelose sodium and dicalcium phosphate 
were also obtained gratis from Mitushi 
Pharma Gujarat, India. All other chemicals 
used were of analytical grade. 
 
Collection of plant material 
 
The barks of Saraca indica were collected 
from the campus of College of 
Pharmaceutical Sciences, Mohuda, India and 
was authenticated by Prof SK Dash, PG Dept 
of Biosciences, Berhampur University, India. 
A voucher specimen (0623/10/PGDB/BU) 
was deposited in the department’s herbarium 
for future reference. The barks were dried 
under shade, powdered and passed through 
nominal mesh with aperture of 180μm. 
 
Phytochemical characterization of the 
plant powder 
 
The Saraca indica bark powder was 
subjected to various phytochemical analysis 
including acid insoluble ash, total ash, foreign 
organic matter, alcohol soluble extractive and 
water soluble extractive [6]. Mean tannin was 
determined using a UV-Visible 
spectrophotometer (UV-2450, Shimadzu, 
Japan) at max  274 nm [7].  
 
Preparation of granules  
 
The wet granulation method of massing and 
screening was used with a batch size of 1000 
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tablets. Saraca indica bark powder (500 g), 
Avicel pH101 (50 g) and starch (25 g) were 
dry mixed in a wet granulator (WGS, Kalweka 
Series, Karnavati Engineering Ltd, India). The 
dry mix was moistened with an appropriate 
amount of cross-caramelose slurry (5 %), 
mixed well in the granulator and passed 
through a sieve with aperture of 1000µm. The 
granules were dried in a hot air oven (Hicon 
India Ltd, India) for 4 h at 60 0C and then re-
sieved through sieve with aperture of 
1000µm. Talc and magnesium stearate (1 
%w/w) were added and mixed for 4 min in a 
cube mixer (Kalweka series, Karnavati 
Engineering Ltd, India).  
 
Preparation of direct compression (DC) 
formulation 
 
In direct compression method, Saraca indica 
bark powder (500 g), Avicel pH 102 (75 g), 
dicalcium phosphate (25 g) and talc (10 gm) 
were mixed in a cube mixer (Kalweka series, 
Karnavati Engineering Ltd, India) based on a 
batch size of 1000 tablets. 
 
Fundamental powder and granule 
properties 
Bulk and tap density 
 
The bulk and tap density of Saraca indica 
bark powder and formulations was 
determined by tapping method (n = 10) using 
data obtained from a digital tap density 
apparatus (Electrolab Ltd, India). 
Flow rate 
The flow rate [8] of the Saraca indica bark 
powder and the granules were determined as 
the ratio of mass (g) to time (seconds) using 
a steel funnel with an orifice diameter of 10 




Flowability was determined using the 
Kawakita analysis [9]. The bark powder or 
formulation (10 g) was poured into a 50 ml 
glass measuring cylinder, the heap of the 
particles in the cylinder was leveled off 
horizontally with a thin metallic spatula, and 
the bulk volume, Vo, was accurately 
measured. The cylinder was then tapped 
mechanically and the change in volume of the 
powder column, VN,   was noted after tapping. 
The compactibility and cohesiveness of both 
the powder and granules were evaluated 
using numerical constants obtained from the 
Kawakita plots based the Kawakita equation, 
which is used for assessing the flow 






 ……………………   (2)  
where a and b are constants; a describes 
the degree of volume reduction at the 
limit of tapping and is called 
compactibility; 1/b is considered to be a 
constant related to cohesion and is called 
cohesiveness, C. The degree of volume 
reduction was calculated from the initial 
volume (V0) and tapped volume (VN)  as 





VVC N       ……………… (3) 
 
Numerical values for constants a and 1/b 
were obtained from the slope of plots of N/C 
versus number of taps N (N = 10, 20, 30, up 
to 300). 
 
Preparation of compacts 
 
Compacts containing 500 mg of Saraca 
indica were made from either the bark 
powder, wet granulated or direct compression 
formulations, using a hydraulic pellet press 
(Kimaya Engineers, India) at compression 
loads ranging from 10  to 95 kg/cm2. Ten flat-
faced 13 mm diameter compacts were made 
at each compression load. Prior to 
compression, the die and punches were 
lubricated with a 2 %w/v dispersion of 
magnesium stearate in ethanol/ether (1:1). 
The compacts were stored over silica gel for 
24 hours (to allow for elastic recovery and 
hardening, and thus avoid false low yield 
values) prior to evaluation. The dimensions 
(thickness and diameter) and weight 
uniformity of three compacts were 
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determined. The relative density ( r ) was 
calculated as the ratio of apparent density 
( A ) of the compact to the true density ( T ) 









The data obtained were applied to obtain 
Heckel plots. Linear regression analysis was 
carried out over a compression range of 10 to 
95 kg/cm2 and parameters from Heckel plots 
[10] were calculated. The compaction 
characteristics of the powder were analysed 





1ln   ……………………   (5)                                
where, r  is the relative density of the 
compact, P the applied pressure, K (the slope 
of the linear portion of the plot) the reciprocal 
of the yield pressure, Py, of the material, and 
A (intercept). The yield pressure is inversely 
related to the ability of the material to deform 
plastically under pressure and A is a function 




For compactibility assessment, the force 
required for diametral breaking of the 
compacts was determined using a digital 
hardness tester (EH-01, Electrolab Ltd, 
India). Tensile strength ( x ) of the compacts 
was calculated using Eq 6 [11].  




 2                                           (6) 
where, x  is hardness (in kg/cm2), and d and 
t are the diameter and thickness of the 
compacts (in mm), respectively. Leuenberger 
analysis was performed by fitting the data to 
Eq 7 [12]. A nonlinear plot of tensile strength 
versus the product of compaction pressure 
(P) and relative density ( r ) was obtained 





re    ………….. (7) 
 
where maxx is maximum tensile strength 
(kg/cm2) when P will be infinite and r  will 
be equal to 1, and γ is compression 
susceptibility. 
 
Preparation of tablet 
 
Tablets containing 500 mg of Saraca indica 
bark powder were produced by compressing 
the granules using a single station tablet 
punching machine (Cadmach Machinery Co 
Pvt Ltd, India) equipped with 13 mm circular, 
flat–faced punches. 
 
Determination of brittle fracture index  
(BFI) 
 
Crack theory can be used to develop a 
quantitative expression for the measurement 
of the brittle fracture tendency [13]. The BFI 






TBFI   
where To and T are the tensile strengths of 
tablets with and without a central hole, 
respectively. The centre hole (≤ 1.2 mm) is a 
built-in model defect to simulate actual void 
formed in the tablet during compression. For 
brittle fracture to occur, the ratio T/To
 
= 3. By 
subtracting 1 and multiplying by 0.5, the 
maximal BFI value is 1 (unity). The BFI value 
thus has a range of 0 (no fracture tendency) 
to 1 (maximal fracture tendency). Tablet 
samples with BFI values (≥ 0.5) display a 
high fracture incidence during actual 
tableting.  
 
Physical characterization of tablets 
 
Saraca indica bark powder tablets prepared 
by wet granulation and direct compression 
were subjected to some physical tests. 
Weight variation was determined by weighing 
20 tablets individually, the mean weight was 
Singh et al 
Trop J Pharm Res, June 2012;11(3): 391 
calculated and the percent variation of each 
tablet from the mean was determined. 
Hardness was determined with a digital tablet 
hardness tester (Electrolab Pvt Ltd, India) on 
6 randomly selected tablets from each 
formulation and the mean applied pressure 
(kg/cm2) to crush the tablets was computed. 
Friability was determined by first weighing 10 
tablets and placing them in a friability tester 
(Electrolab Pvt. Ltd., India), which was 
rotated for 4 min at 25 rpm. After dusting the 
tablets, their total weight was again recorded 
and the percent weight difference recorded 
as friability. The disintegration time of six 
tablets per formulation was determined in 900 
ml of distilled water using a disintegration test 
apparatus (Electrolab Pvt Ltd, India).  
 
In-vitro dissolution test 
 
Release of pure tannin [15] from the tablets 
of Saraca indica bark powder was 
determined using a USP XXI six-station 
dissolution test apparatus I (Disso 2000, 
Labindia) at 50 rpm. The dissolution medium 
was 900 ml 0.1M HCl and the temperature 
was maintained at 37 ±  0.2 0C. Samples of 5 
ml each were withdrawn at 5, 10, 20, 30, 40, 
50 and 60 min time intervals, filtered through 
Whatman filter (0.45 μm, Auroco Pvt Ltd, 
Thailand) and replaced with an equal amount 
of fresh dissolution medium in each instance. 
The samples were suitably diluted and 
analyzed for tannin content using a 
UV/Visible double-beam spectrophotometer 
(UV-2450, Shimadzu, Japan) at 274 nm. The 
amount of tannin was calculated from the 
calibration curve of standard tannin. The 




Statistical analysis was carried out on the 
data to determine the differences between 
the bark powder and its formulations 
prepared by wet granulation and direct 
compression. This was achieved by carrying 
out a one-way ANOVA at p < 0.05 level using 
software GraphPad Prism® 4 software 
(GraphPad Software Inc, San Diego, USA). 
At a 95 % confidence interval, a calculated f-
value of more than the critical f-value was 
considered significant. Paired t-test was 
carried out to ascertain any significant 
difference between release data for 
formulations prepared by wet granulation and 
direct compression. At a 95 % confidence 
interval, t-values less than or equal to the 




Basic powder parameters and drug 
content 
 
Acid insoluble ash (0.70 ± 0.25 %), total ash 
(5.5 ± 1.0 %), alcohol soluble extractive (40.0 
± 1.5 %) and water soluble extractive (65.9 ± 
2.5 %) were within the limits of Ayurvedic 
Pharmacopoeia of India [6]. Mean content of 
tannin in 100 mg of bark powder was 30 ± 2 
mg calculated as tannin with reference to the 
tannin reference standard [7].      
 
Physicochemical properties of powder 
and granule  
 
The flow rate of direct compression 
formulation (1.46 ± 0.57 g/sec) and granules 
(2.58 ± 0.11 g/sec) indicate that there was a 
significant difference (p < 0.05) in flowability 
between the two forms. Thus, the flow 
properties of Saraca indica bark powder were 
poor for direct processing into tablet dosage 
form. Bulk density and tapped density were 
0.253 ± 0.010 and 0.385 ± 0.050, 0.285 ± 
0.051 and 0.415 ± 0.025, 0.361 ± 0.040 and 
0.456 ± 0.090 g/cm3 for powder, direct 





Plots of N/C versus N (Kawakita plots) for 
Saraca indica bark powder, direct 
compression formulation and granule gave a 
linear relationship in each case. The 
constants, a and 1/b, of the Kawakita 
equation were resolved from the slope and 
intercept  of  the  line  plot  of  N/C versus N,  
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Table 1: Heckel data for the preparations 
 




Bark powder 0.078  ± 0.004 2.439 ± 0.120 220 ± 5 0.9956 
DC formulation  0.081 ± 0.003 2.898 ± 0.330 180 ± 5 0.9984 









Note: All values are expressed as mean ± SD, n = 10; * Significant difference at p < 0.05 level  
 












Figure 1: Heckel plot for Saraca indica bark 
powder (◊), direct compression formulation (▼) 
and granules (Δ); mean ± SD, n = 10).   
 
and found to be 0.376 ± 0.087 and 6.176 ± 
1.030 for powders, 0.304 ± 0.088 and 5.443 
± 1.230 for DC formulations and 0.209 ± 





Heckel data (Figure 1 and Table 1) for direct 
compression formulation and granule show 
no linearity at the early stages of 
compression due to particle rearrangement 
and the initial fragmentation. The higher 
value of intercept (A) for granules (4.38 ± 
0.45) implies a higher degree of 
fragmentation than for DC formulation (2.90 ± 
0.33) and powder (2.90 ± 0.33). When the 
compression pressure was increased, the 
granules showed plastic deformation [16]. 
The greater slope indicates a greater degree 
of plasticity of granules (0.099 ± 0.006) than 
those of DC formulation (0.081 ± 0.003) and 
powder (0.078 ± 0.004), hence better 




The compression susceptibility data (Figure 
2c) for compact formed by wet granulation 
technique (0.1825 ± 0.045 1/kg/cm2) indicate 
that the maximum crushing strength was 
reached faster at lower pressures of 
compression compared to bark powder 
compact (0.073 ± 0.025 1/kg/cm2), as shown 
in Figure. 2a. Table 2 demonstrate that 
granules produced higher tensile strength 
(7.40 ± 0.36 kg/cm2) than direct compression 
formulation (3.48 ± 0.63 kg/cm2) and powder 
(0.98 ± 0.45 kg/cm2), and this shows that 
granules of the plant bark was capable of 
yielding a compact with a higher strength 
than direct compression formulation (Figure. 
2b).  
 
The one-way ANOVA data in Tables 1 and 2 
show that the calculated f-value was much 
higher than the critical f-value for all the 
parameters (p < 0.05), thus indicating that 
there was significant improvement in 
flowability and compressibility following 
granulation. 
 
Physical characteristics of the tablets 
 
All the batches of tablets were produced 
under similar conditions to avoid processing 
variables. Weight variation for the Saraca 
indica tablets prepared by wet granulation 
and direct compression method were in the 
range of 600 ± 14 and 610 ± 16 mg, 
respectively, while tablet hardness was 
higher for tablets prepared by wet granulation  
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Bark powder  0.07324 ± 0.025 0.9773 ± 0.45 0.9429 
DC formulation  0.105 ± 0.033 3.48 ± 0.63 0.8542 







Note: All values are expressed as mean ± SD, n=10; *Significant difference at p < 0.05 
 
  



















   
Figure 2: Plot of radial crushing strength against the product of pressure of compression pressure and 
relative density of Saraca indica bark for (a) powder (b) direct compression formulation, and (c) granules  
 
(5.50 ± 1.15 kg/cm2) than by direct 
compression (4.60 ± 1.31 kg/cm2), and tablet 
thickness was 3.90 ± 0.05 and 4.10 ± 0.06 
mm, respectively. Other data for tablets 
prepared by direct compression and wet 
granulation were 0.77 ± 0.28 and 0.43 ± 0.16 
%, respectively, for friability; and 12.0 ± 1.5 
and 15.0 ± 1.9 min, respectively, for 
disintegration time.  
 
Brittle fracture index 
 
The brittle fracture index (BFI) was 0.294 and 
0.398 for tablets prepared by wet granulation 
and direct compression methods, 
respectively. 
 
In-vitro dissolution  
 
As Figure 3 indicates, more than 90 % of 
tannin was released within 30 min from 
tablets prepared by wet granulation while DC 
tablets released more than 90 % of tannin 




Fundamental powder and granule 
properties 
 
One of the most important factors affecting 
bulk density of a powder and its flow 
properties is interparticulate interaction (8). 
Suboptimal presence of water diminishes the 
cohesiveness of powder, resulting in 
increased bulk density for granule and direct 
compression formulations and hence, 
enhanced flowability (17). On the other hand, 
increased tapped density of granule and 
direct compression formulation indicate better 
degree of compactibility as a function of 
applied pressure (18).  







(a) (b) (c) 
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Figure 3: Dissolution profile of tablets of Saraca 
indica bark prepared by wet granulation (□) and 
direct compression (▲) in simulated gastric fluid 
(SGF). 
 
From Kawakita analysis, it was found that 
granules densified the least (small 
compressible value) but attained the final 
packing state more slowly than DC 
formulation and powder. The lower values of 
a and 1/b for the granule formulation 
indicate better flowability and lesser 
cohesiveness than the direct compression 
formulation (19). 
 
Heckel analysis showed that granule 
formulation exhibited higher value for die 
filling in the initial stages of rearrangement, 
as indicated by A (intercept) value. This 
behaviour could result in the formation of 
bridges and arches, which would in turn 
prevent close packing of the particles in the 
bulk state. Hence,  mean yield pressure, Py, 
values were lower for the granule 
formulation than for the other formulations 
(Table 1). The results, therefore, indicate 
that the granules underwent plastic 
deformation more easily than the direct 
compression (DC) formulation. This also 
confirms that the direct compression 
formulation is somewhat resistant to 
deformation.  
  
Leuenberger analysis allow maximum tensile 
strength and compression susceptibility to be 
applied to facilitate the characterization of the 
different materials (20). The low maximum 
tensile strength of Saraca indica bark powder 
indicate poor bonding properties. In this 
regard, Saraca indica granule and DC 
formulations showed moderate bonding 
properties. More than 90 % of the drug was 
released within 30 min for tablets prepared by 
wet granulation method compared with 60 
min for DC formulations.  
 
BFI data revealed that tablets prepared from 
granules exhibited lower fracture, capping 




Both wet granulation and direct compression 
methods can be used successfully for 
developing suitable tablet f orm ulat i ons of  
Saraca indica bark. The approach employed 
in this study may be applicable to the 
development of other herbal drugs and 
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